When: Weekly close below $165

Then: Invalidates medium-term recovery thesis

Maintain benchmark weight; do not add exposure ahead of Q4 FY26 earnings; wait for the print to confirm or deny the thesis before adjusting position

• Morgan Stanley raised price target to $175 on September 14th, but stock trades at $183-$197, meaning the most bullish major bank still sees value below current market price
• Anthropic deal represents speculative future revenue, not contracted revenue; even $500M-$1B in related bookings over three years represents under 1.5% of Accenture's $73B annual revenue
• Over $900M in unusual charges across just the last two quarters represent real costs on prior acquisitions not performing as expected
• AI tools present genuine secular threat to consulting revenue with AI-native alternatives now competing against acquired businesses
• Technical setup is bearish: price below 10 EMA and 20 SMA middle band, MACD below signal line with negative widening histogram, and rejected twice at 200 SMA ($196-$197)
• Asymmetric setup is flawed: realistic upside is $190-$195, but downside on disappointment could be $150 or lower versus June 18 low of $118
• Fed raised rates for the first time since 2023 with Polymarket pricing 96% probability of zero cuts in 2026, creating structural headwind for multiple expansion
• 14.66x P/E and 10.8% FCF yield are compelling because the market is pricing in legitimate AI disruption, demand softness, and macro risks
• The June rally from $118 shows what downside looks like when sentiment turns, making the downside window materially wider than the upside in a disappointment scenario

→ vs aggressive: Anthropic TAM framing treats speculative future revenue as contracted; even optimistic $500M-$1B over three years is under 1.5% of top line and Morgan Stanley had five business days to update their model after the deal and chose not to

→ vs aggressive: Cloud security analogy represents survivorship bias; every strategy consultant in 2010 made similar bets and most failed, making the $112 billion market cap bet more like venture capital than conservative investing

→ vs aggressive: Goodwill risk characterization as phantom ignores $900M+ in unusual charges over two quarters that represent real costs on underperforming acquisitions competing against AI-native alternatives

→ vs aggressive: Technical analysis cherry-picks bullish indicators (VWMA rally from $139 to $186) while ignoring bearish signals including price below three key moving averages and double rejection at 200 SMA

→ vs aggressive: Asymmetric setup math is flawed; $200 target isn't credible given 200 SMA rejection acting as heavy supply, while downside could reach $150 or lower in a sentiment shift versus idealized $172 stop

→ vs aggressive: Multiple expansion to 18-20x forward EPS requires earnings acceleration or friendlier rate environment, neither of which exists with hawkish Fed pivot and downside skewed earnings outlook

HOLD at benchmark weight with defined catalyst-based adjustments; stop at $172 with hard exit at $165; add to overweight if Q4 prints with FY27 guide at 6%+ and stock holds $190; trim to underweight if organic growth below 5% and stock breaks $180 on earnings.

• Anthropic deal is a positive expected value option but should not drive position sizing—described as a tiebreaker, not a thesis
• Morgan Stanley $175 price target below current trading price signals smart money disagreement with current valuation
• Goodwill risk is a multi-year slow burn rather than imminent event—steady accumulation of smaller charges plus potential FY27 restructuring
• Technical regime is transitional: medium-term recovery intact above 50 SMA, long-term downtrend intact below 200 SMA, short-term momentum stalled per MACD
• Asymmetric setup math from aggressive analyst is flawed because downside is not capped at 50 SMA—a 20% decline to $150 is low probability but non-zero and wipes out multiple sessions of upside
• Valuation metrics of 14.66x P/E and 10.8% FCF yield are compelling but earned through 47% year-to-date underperformance
• Current multiple is too low for bull case and too high for downside case—multiple expansion requires Q4 FY26 catalyst to resolve ambiguity
• ATR at 4% of price means even benchmark weight generates meaningful mark-to-market volatility—name not suitable for overcommitment

→ vs aggressive: Asymmetry math depends on the assumption that downside is capped at the 50 SMA ($172); without that assumption the setup is neutral, not positively skewed. Also overstates 40-60% upside being left on table by not adding today because the expected value calculation must include probability of disappointment scenario which continues to be underweighted.

→ vs conservative: Overconfident about what the next 30 days will tell us; earnings prints frequently produce noise rather than signal in the first 24 hours. Also fails to acknowledge that current valuation may be underweighting Anthropic optionality and potential Fed pause over next six months.